Glycemic control and the first use of oral antidiabetic agents among patients with type 2 diabetes mellitus

By Mitchell Beth D.   Eby Elizabeth L.   Lage Maureen J.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1587-1597

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular risks associated with second‐line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study

By  

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1460-1469

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization

By Cooke Catherine E.   Lee Helen Y.   Tong Yvette P.   Haines Stuart T.  

Current Medical Research and Opinion, Vol. 26, Iss. 1, 2010-01 ,pp. : 231-238

Informa Healthcare

Access to resources Recommend Favorite

Increasing awareness of hypoglycaemia in patients with Type 2 diabetes treated with oral agents

By Barnett A.H.   Brice R.   Hanif W.   James J.   Langerman H.  

Current Medical Research and Opinion, Vol. 29, Iss. 11, 2013-11 ,pp. : 1503-1513

Informa Healthcare

Access to resources Recommend Favorite

Oral antidiabetic drug therapy in type 2 diabetes mellitus - focus on elderly patients

By Lechleitner Monika  

Wiener Medizinische Wochenschrift, Vol. 161, Iss. 11-12, 2011-06 ,pp. : 297-299

Springer Publishing Company

Access to resources Recommend Favorite